Medicare Enrolled

Dr. Latrice Akuamoah, M.D.

Pain Medicine · Hoboken, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
720 MONROE ST STE C208, Hoboken, NJ 07030
2015339200
In practice since 2011 (15 years)
NPI: 1497047955 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Akuamoah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Akuamoah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Akuamoah

Dr. Latrice Akuamoah is a pain medicine specialist in Hoboken, NJ, with 15 years of NPI registration. Based on federal Medicare data, Dr. Akuamoah performed 1,445 Medicare services across 394 unique beneficiaries.

Between the years covered by Open Payments, Dr. Akuamoah received a total of $20,204 from 41 pharmaceutical and/or device companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Akuamoah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 28% volume in NJ $20,204 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,445
Medicare services
Top 28% in NJ for pain medicine
394
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~96 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
532 $111 $400
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
485 $0 $1
Drug test, instrument-assisted
A laboratory test to detect the presence of drugs using an instrument for observation.
99 $17 $50
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
89 $195 $800
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
66 $66 $350
Contrast dye for imaging, lower concentration 38 $0 $5
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
34 $144 $450
Anesthesia for spine injection or aspiration with imaging
This code covers the administration of anesthesia for injection, drainage, or aspiration procedures on the lower back spine or spinal cord. The procedure is performed through the skin using imaging guidance.
26 $92 $943
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
23 $108 $728
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
19 $129 $1,000
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
19 $72 $700
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
15 $93 $1,000
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$20,204
Total received (2018-2024)
Avg $2,886/year across 7 years
Top 6% in NJ for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
282
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,204 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,355
2023
$2,819
2022
$2,433
2021
$2,430
2020
$1,392
2019
$2,127
2018
$1,647

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Saluda Medical Americas, Inc.
$2,315
Genesys Orthopedics Systems, L.L.C.
$1,267
Abbott Laboratories
$1,104
Boston Scientific Corporation
$992
PAINTEQ LLC
$322
Medtronic, Inc.
$301
MML US, Inc.
$268
SPR Therapeutics, Inc
$173
Nalu Medical, Inc.
$163
Collegium Pharmaceutical, Inc.
$121
Vertos Medical, Inc.
$72
BIOTRONIK NRO, Inc.
$66
DePuy Synthes Sales Inc.
$50
VERTEX PHARMACEUTICALS INCORPORATED
$40
PFIZER INC.
$40
Valinor Pharma, LLC
$24
Nevro Corp.
$20
PROTEGA PHARMACEUTIALS INC
$19
Top 3 companies account for 63.7% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$3,738
Boston Scientific Corporation
$3,522
Saluda Medical Americas, Inc.
$2,378
PAINTEQ LLC
$1,372
BOSTON SCIENTIFIC CORPORATION
$1,297
Genesys Orthopedics Systems, L.L.C.
$1,267
Medtronic, Inc.
$1,002
MML US, Inc.
$762
Nevro Corp.
$624
Vertos Medical, Inc.
$624
Collegium Pharmaceutical, Inc.
$396
Medtronic USA, Inc.
$380
PFIZER INC.
$361
Nalu Medical, Inc.
$347
Relievant Medsystems, Inc.
$325
Biohaven Pharmaceutical Holding Company Ltd.
$201
BioDelivery Sciences International, Inc.
$188
SPR Therapeutics, Inc
$173
Stimwave Technologies Incorporated
$157
Scilex Pharmaceuticals Inc.
$129
Alexion Pharmaceuticals, Inc.
$125
Vertiflex, Inc.
$118
Assertio Therapeutics, Inc.
$83
Biohaven Pharmaceuticals, Inc.
$75
Zimmer Biomet Holdings, Inc.
$73
BIOTRONIK NRO, Inc.
$66
DePuy Synthes Sales Inc.
$50
IBSA Pharma Inc.
$42
Teva Pharmaceuticals USA, Inc.
$41
VERTEX PHARMACEUTICALS INCORPORATED
$40
Forte Bio-Pharma LLC
$34
Pernix Therapeutics Holdings, Inc.
$32
Kowa Pharmaceuticals America, Inc.
$29
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$27
Valinor Pharma, LLC
$24
SI-BONE, Inc.
$20
PROTEGA PHARMACEUTIALS INC
$19
SI-BONE, INC.
$19
SCILEX PHARMACEUTICALS INC.
$18
Virtus Pharmaceuticals LLC
$18
FORTE BIO-PHARMA LLC
$6
Top 3 companies account for 47.7% of all-time payments
Associated products mentioned in payments ›
AJOVY · AXIUM · Axium INS DRG IPG · BELBUCA · BUNAVAIL 2.1 mg 30-count box · CHANTIX · ETERNA · Evoke · Evoke SCS · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · General - Pain Management · Gralise · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LEVORPHANOL TARTRATE · LICART · LYRICA · MOVANTIK · Mobi-C · NALOCET · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OCTRODE · ORTHOVISC · Omnia · PAINTEQ · PROCLAIM · PROLATE · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prospera · ROXYBOND · ReActiv8 · SACROILIAC JOINT FUSION SYSTEM · SCS IPGs · SEGLENTIS · SPECTRA WAVEWRITER · SPRINT PNS System · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Spectra WaveWriter · StimQ Receiver Stimulator Kit Channel A US w Receiver · Superion ISS · VECTRIS · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for pain medicine in NJ.

Looking for a pain medicine specialist in Hoboken?
Compare pain medicines in the Hoboken area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
207
Per 100K population
29.1
County median income
$90,032
Nearest hospital
CAREPOINT HEALTH-HOBOKEN UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Akuamoah is a clinical cardiology specialist, with above-average Medicare volume (top 28% in NJ), with low-engagement industry engagement in the top 6% of NJ peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Akuamoah experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Akuamoah performed 532 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Akuamoah receive payments from pharmaceutical companies?
Yes. Dr. Akuamoah received a total of $20,204 from 41 companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Akuamoah's costs compare to other pain medicines in Hoboken?
Dr. Akuamoah's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Akuamoah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →